Additionally, our data provide evidence for the role played by Syndecan-1 in synchronously fine tuning multiple signaling pathways including IL-6/STAT3/gp130, inflammatory cytokines, Notch, and EGFR, implicated in breast cancer stemness (Fig. 10). This evidence concerns the gene SDC1 and breast carcinoma.